Phathom Pharmaceuticals Inc's Suppliers Performance

Name: Phathom Pharmaceuticals Inc 's (PHAT) Suppliers by Company, Division and Industry - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use

PHAT's Supply Chain

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.


PHAT Costs vs Sales of Suppliers Growth		Phathom Pharmaceuticals Inc recorded an increase in cost of sales by 199.64 % year on year, sequentially cost of sales grew by 25.84 % in Q2. • More on PHAT Suppliers

Phathom Pharmaceuticals Inc recorded increase in cost of sales by 199.64 % year on year, sequentially cost of sales grew by 25.84 % in Q2.

• More on PHAT Suppliers

Select the Relationship:

Suppliers ▼

Select the Category:

Comparison ▼

Suppliers ▼

Basic Report▼

Phathom Pharmaceuticals Inc's Comment on Supply Chain

The company sources raw materials and manufactures vonoprazan and related products through third-party suppliers Catalent, Evonik, and Sandoz. Catalent and Evonik produce vonoprazan drug substance and drug product, while Sandoz manufactures amoxicillin and clarithromycin and handles packaging for antibiotics and vonoprazan. All supplier facilities are FDA-approved and undergo regular inspections to maintain compliance with current Good Manufacturing Practices (cGMP) and regulatory standards. The company acknowledges a potential risk of supply disruption, particularly concerning Sandoz's supply of clarithromycin tablets used in VOQUEZNA TRIPLE PAK, although no immediate disruptions are expected. The company’s reliance on these third-party manufacturers for regulatory compliance and production presents a risk that any manufacturing or regulatory issues could adversely affect product commercialization and development.

Phathom Pharmaceuticals Inc's Comment on Supply Chain

PHAT's Stock Perfrormance relative to it's Suppliers

PHAT's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

COMPANY NAME	MARKET CAP	REVENUES	INCOME	EMPLOYEES
Phathom Pharmaceuticals Inc	584.97	239.66	-99.07	371
SUBTOTAL	0.00	0.00	0.00	-

Sources: Phathom Pharmaceuticals Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on: Friday, September 18, 2026 5:57 PM
For your research, we’ve provided nine additional tables on Phathom Pharmaceuticals Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.